| Line Item | 2025-02-02 | Y/Y |
|---|---|---|
| Revenue | $3.17B | +11.9% |
| Cost of Revenue | $955.5M | +18.0% |
| Gross Profit | $2.21B | +9.5% |
| R&D Expense | $804.4M | +9.2% |
| SG&A Expense | $286.2M | +13.5% |
| Operating Income | $85.3M | +59.2% |
| Pre-tax Income | $147.8M | +63.2% |
| Income Tax | $41.1M | +40.4% |
| Net Income | $106.7M |
| Line Item | 2025-02-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $723.6M | +3.0% |
| Accounts Receivable | $680.9M | +2.8% |
| Inventory | $42.8M | +0.3% |
| Current Assets | $2.57B | +2.8% |
| Total Assets | $3.96B | +8.4% |
| Current Liabilities | $1.60B | +16.9% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2025-02-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | $753.6M | +11.2% |
| Capital Expenditures | $226.7M | +16.2% |
| Investing Cash Flow | -$218.2M | -6822.1% |
| Financing Cash Flow | -$509.8M | +9.0% |
| Free Cash Flow | $526.9M | +9.2% |
| +74.1% |
| EPS (Basic) | $0.33 | +65.0% |
| EPS (Diluted) | $0.31 | +63.2% |
| Total Liabilities |
| $2.66B |
| +11.4% |
| Stockholders' Equity | $1.31B | +2.9% |